382 related articles for article (PubMed ID: 29045907)
1. Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.
Glodde N; Bald T; van den Boorn-Konijnenberg D; Nakamura K; O'Donnell JS; Szczepanski S; Brandes M; Eickhoff S; Das I; Shridhar N; Hinze D; Rogava M; van der Sluis TC; Ruotsalainen JJ; Gaffal E; Landsberg J; Ludwig KU; Wilhelm C; Riek-Burchardt M; Müller AJ; Gebhardt C; Scolyer RA; Long GV; Janzen V; Teng MWL; Kastenmüller W; Mazzone M; Smyth MJ; Tüting T; Hölzel M
Immunity; 2017 Oct; 47(4):789-802.e9. PubMed ID: 29045907
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
Marshall NA; Galvin KC; Corcoran AM; Boon L; Higgs R; Mills KH
Cancer Res; 2012 Feb; 72(3):581-91. PubMed ID: 22158905
[TBL] [Abstract][Full Text] [Related]
3. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
[TBL] [Abstract][Full Text] [Related]
4. Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment.
Kim KD; Bae S; Capece T; Nedelkovska H; de Rubio RG; Smrcka AV; Jun CD; Jung W; Park B; Kim TI; Kim M
Nat Commun; 2017 May; 8():15365. PubMed ID: 28504276
[TBL] [Abstract][Full Text] [Related]
5. The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
Ilangumaran S; Villalobos-Hernandez A; Bobbala D; Ramanathan S
Cytokine; 2016 Jun; 82():125-39. PubMed ID: 26822708
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells.
Jiang L; Fang X; Wang H; Li D; Wang X
Front Immunol; 2018; 9():2927. PubMed ID: 30619288
[TBL] [Abstract][Full Text] [Related]
7. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
Li J; Hu P; Khawli LA; Epstein AL
Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy.
Lechner MG; Karimi SS; Barry-Holson K; Angell TE; Murphy KA; Church CH; Ohlfest JR; Hu P; Epstein AL
J Immunother; 2013; 36(9):477-89. PubMed ID: 24145359
[TBL] [Abstract][Full Text] [Related]
9. The c-MET receptor tyrosine kinase contributes to neutrophil-driven pathology in cutaneous leishmaniasis.
Passelli K; Prat-Luri B; Merlot M; Goris M; Mazzone M; Tacchini-Cottier F
PLoS Pathog; 2022 Jan; 18(1):e1010247. PubMed ID: 35041723
[TBL] [Abstract][Full Text] [Related]
10. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
[TBL] [Abstract][Full Text] [Related]
11. Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer.
Kobold S; Steffen J; Chaloupka M; Grassmann S; Henkel J; Castoldi R; Zeng Y; Chmielewski M; Schmollinger JC; Schnurr M; Rothenfußer S; Schendel DJ; Abken H; Sustmann C; Niederfellner G; Klein C; Bourquin C; Endres S
J Natl Cancer Inst; 2015 Jan; 107(1):364. PubMed ID: 25424197
[TBL] [Abstract][Full Text] [Related]
12. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
13. Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance.
Zheng W; Skowron KB; Namm JP; Burnette B; Fernandez C; Arina A; Liang H; Spiotto MT; Posner MC; Fu YX; Weichselbaum RR
Oncotarget; 2016 Jul; 7(28):43039-43051. PubMed ID: 27343548
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers.
Ekiz HA; Huffaker TB; Grossmann AH; Stephens WZ; Williams MA; Round JL; O'Connell RM
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30721153
[TBL] [Abstract][Full Text] [Related]
15. HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer.
Fan G; Zhang S; Gao Y; Greer PA; Tonks NK
Genes Dev; 2016 Jul; 30(13):1542-57. PubMed ID: 27401557
[TBL] [Abstract][Full Text] [Related]
16. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
[TBL] [Abstract][Full Text] [Related]
17. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
18. MET is required for the recruitment of anti-tumoural neutrophils.
Finisguerra V; Di Conza G; Di Matteo M; Serneels J; Costa S; Thompson AA; Wauters E; Walmsley S; Prenen H; Granot Z; Casazza A; Mazzone M
Nature; 2015 Jun; 522(7556):349-53. PubMed ID: 25985180
[TBL] [Abstract][Full Text] [Related]
19. Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment.
Wallecha A; Singh R; Malinina I
J Immunother; 2013; 36(9):468-76. PubMed ID: 24145358
[TBL] [Abstract][Full Text] [Related]
20. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]